Esendagli-Yilmaz G - Search Results

1

ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.

Vilarinho S, Sari S, Mazzacuva F, Bilgüvar K, Esendagli-Yilmaz G, Jain D, Akyol G, Dalgiç B, Günel M, Clayton PT, Lifton RP. Vilarinho S, et al. Among authors: esendagli yilmaz g. Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11289-11293. doi: 10.1073/pnas.1613228113. Epub 2016 Sep 19. Proc Natl Acad Sci U S A. 2016. PMID: 27647924 Free PMC article.

2

Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker.

Akdoğan Ö, Atak Yücel A, Gök Sargin Z, Sönmez C, Esendağli Yilmaz G, Özenirler S. Akdoğan Ö, et al. Among authors: esendagli yilmaz g. J Clin Exp Hepatol. 2019 Jan-Feb;9(1):29-33. doi: 10.1016/j.jceh.2018.02.001. Epub 2018 Feb 16. J Clin Exp Hepatol. 2019. PMID: 30765936 Free PMC article.

3

Crizotinib-induced toxicity in an experimental rat model.

Gumusay O, Esendagli-Yilmaz G, Uner A, Cetin B, Buyukberber S, Benekli M, Ilhan MN, Coskun U, Gulbahar O, Ozet A. Gumusay O, et al. Among authors: esendagli yilmaz g. Wien Klin Wochenschr. 2016 Jun;128(11-12):435-41. doi: 10.1007/s00508-016-0984-y. Epub 2016 Mar 14. Wien Klin Wochenschr. 2016. PMID: 26975454

4

Dual actions of the antioxidant chlorophyllin, a glutathione transferase P1-1 inhibitor, in tumorigenesis and tumor progression.

Ozcan M, Esendagli G, Musdal Y, Canpinar H, Bacanlı M, Anlar HG, Esendağlı-Yılmaz G, Beyramzadeh M, Aksoy Y. Ozcan M, et al. Among authors: esendagli yilmaz g. J Cell Biochem. 2019 May;120(5):7045-7055. doi: 10.1002/jcb.27974. Epub 2018 Nov 28. J Cell Biochem. 2019. PMID: 30484884

5

Is There Any Association Between Mammographic Features of Microcalcifications and Breast Cancer Subtypes in Ductal Carcinoma In Situ?

Avdan Aslan A, Gültekin S, Esendağli Yilmaz G, Kurukahvecioğlu O. Avdan Aslan A, et al. Among authors: esendagli yilmaz g. Acad Radiol. 2021 Jul;28(7):963-968. doi: 10.1016/j.acra.2020.05.032. Epub 2020 Jun 30. Acad Radiol. 2021. PMID: 32620528

6

Pathologic basis of pyogenic, nonpyogenic, and other spondylitis and discitis.

Esendagli-Yilmaz G, Uluoglu O. Esendagli-Yilmaz G, et al. Neuroimaging Clin N Am. 2015 May;25(2):159-61. doi: 10.1016/j.nic.2015.01.011. Neuroimaging Clin N Am. 2015. PMID: 25952170 Review.

7

Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer.

Erdoğar N, Esendağlı G, Nielsen TT, Esendağlı-Yılmaz G, Yöyen-Ermiş D, Erdoğdu B, Sargon MF, Eroğlu H, Bilensoy E. Erdoğar N, et al. Among authors: esendagli yilmaz g. J Drug Target. 2018 Jan;26(1):66-74. doi: 10.1080/1061186X.2017.1339194. Epub 2017 Jun 25. J Drug Target. 2018. PMID: 28581827

8

CRAM-A indicates IFN-γ-associated inflammatory response in breast cancer.

Sarmadi P, Tunali G, Esendagli-Yilmaz G, Yilmaz KB, Esendagli G. Sarmadi P, et al. Among authors: esendagli yilmaz g. Mol Immunol. 2015 Dec;68(2 Pt C):692-8. doi: 10.1016/j.molimm.2015.10.019. Epub 2015 Nov 10. Mol Immunol. 2015. PMID: 26563945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page